SARS-CoV-2 (D614G Mutant) Spike Glycoprotein (Trimeric), His-Tag (CHO) (500µg) (Special Terms Apply*)
We're always working hard to give our customers as much information on products and the best price possible. If you need any assistance or would like a quote please contact us and we will be happy to help
SARS-CoV-2 (D614G Mutant) Spike Glycoprotein (Trimeric), His-Tag (CHO) (500µg) (Special Terms Apply*) (QTXAG-690-500) is SARS-CoV-2 (D614G mutant) trimeric spike glycoprotein is manufactured in CHO cells to high yield and purity. Protein has the D614G mutation and proline substitutions at residues 986 and 987, a GSAS substitution at the furin cleavage site (residues 682-685), and a C-terminal His-tag.
SARS-CoV-2 (D614G mutant) trimeric spike glycoprotein is manufactured in CHO cells to high yield and purity. Protein has the D614G mutation and proline substitutions at residues 986 and 987, a GSAS substitution at the furin cleavage site (residues 682-685), and a C-terminal His-tag. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
*Special Terms: Please see product specification details below and our Ordering page for details.
Q-TOX Term 2: Minimum Order Volume of 1000µg on Orders Requiring Dry Ice Shipment
